Aptamer-conjugated Gold Nanoparticles and Their Diagnostic and Therapeutic Roles in Cancer

Overview

Journal Front Bioeng Biotechnol

Date 2023 Feb 6

PMID 36741760

Authors

Guozhen Deng

He Zha

Hongzhi Luo

Yi Zhou

Affiliations

Soon will be listed here.

Abstract

The burden of incidence rate and mortality of cancer is increasing rapidly, and the development of precise intervention measures for cancer detection and treatment will help reduce the burden and pain of cancer. At present, the sensitivity and specificity of tumor markers such as CEA and CA-125 used clinically are low, while PET, SPECT, and other imaging diagnoses with high sensitivity possess shortcomings, including long durations to obtain formal reports and the inability to identify the molecular pathological type of cancer. Cancer surgery is limited by stage and easy to recur. Radiotherapy and chemotherapy often cause damage to normal tissues, leading to evident side effects. Aptamers can selectively and exclusively bind to biomarkers and have, therefore, gained attention as ligands to be targeted for cancer detection and treatment. Gold nanoparticles (AuNPs) are considered as promising nano carriers for cancer diagnosis and treatment due to their strong light scattering characteristics, effective biocompatibility, and easy surface modification with targeted agents. The aptamer-gold nanoparticles targeting delivery system developed herein can combine the advantages of aptamers and gold nanoparticles, and shows excellent targeting, high specificity, low immunogenicity, minor side effects, etc., which builds a bridge for cancer markers to be used in early and efficient diagnosis and precise treatment. In this review, we summarize the latest progress in the application of aptamer-modified gold nanoparticles in cancer targeted diagnosis and delivery of therapeutic agents to cancer cells and emphasize the prospects and challenges of transforming these studies into clinical applications.

Citing Articles

Surface Functionalization of Citrate-Stabilized Gold Nanoparticles with Various Disease-Specific Nonthiolated Aptamers: RSM-Based Optimization for Multifactorial Disease Biomarker Detection.

Ebrahimi F, Kumari A, Al Abdullah S, Vivero-Escoto J, Dellinger K ACS Sens. 2025; 10(2):944-953.

PMID: 39960422 PMC: 11877523. DOI: 10.1021/acssensors.4c02722.

Aptamer-decorated nanocarriers for viral adsorption: A special look at COVID-19.

Handali S, Rezaei M Mol Ther Nucleic Acids. 2024; 35(3):102310.

PMID: 39281706 PMC: 11401170. DOI: 10.1016/j.omtn.2024.102310.

Aptamer Based SPREETA Sensor for the Detection of G-Protein.

Park S, Lee H, Ji T, Kim K, Ohk S J Microbiol Biotechnol. 2023; 34(2):289-295.

PMID: 38111313 PMC: 10940744. DOI: 10.4014/jmb.2310.10042.

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges.

Szymanowski W, Szymanowska A, Bielawska A, Lopez-Berestein G, Rodriguez-Aguayo C, Amero P Cancers (Basel). 2023; 15(21).

PMID: 37958473 PMC: 10647731. DOI: 10.3390/cancers15215300.

Does COVID-19 Trigger the Risk for the Development of Parkinson's Disease? Therapeutic Potential of Vitamin C.

Sandeep , Subba R, Chandra Mondal A Mol Neurobiol. 2023; 61(12):9945-9960.

PMID: 37957424 DOI: 10.1007/s12035-023-03756-3.

References

Popovtzer R, Agrawal A, Kotov N, Popovtzer A, Balter J, Carey T . Targeted gold nanoparticles enable molecular CT imaging of cancer. Nano Lett. 2009; 8(12):4593-6. PMC: 2772154. DOI: 10.1021/nl8029114. View

Kim D, Park S, Lee J, Jeong Y, Jon S . Antibiofouling polymer-coated gold nanoparticles as a contrast agent for in vivo X-ray computed tomography imaging. J Am Chem Soc. 2007; 129(24):7661-5. DOI: 10.1021/ja071471p. View

Mirau P, Smith J, Chavez J, Hagen J, Kelley-Loughnane N, Naik R . Structured DNA Aptamer Interactions with Gold Nanoparticles. Langmuir. 2017; 34(5):2139-2146. DOI: 10.1021/acs.langmuir.7b02449. View

Koltai T . Targeting the pH Paradigm at the Bedside: A Practical Approach. Int J Mol Sci. 2020; 21(23). PMC: 7730959. DOI: 10.3390/ijms21239221. View

Zheng J, Ning G, Sun W, Wang L, Liang H, Xu H . A novel affinity peptide-antibody sandwich electrochemical biosensor for PSA based on the signal amplification of MnO-functionalized covalent organic framework. Talanta. 2021; 233:122520. DOI: 10.1016/j.talanta.2021.122520. View

Hung M, Schechter A, Chevray P, Stern D, Weinberg R . Molecular cloning of the neu gene: absence of gross structural alteration in oncogenic alleles. Proc Natl Acad Sci U S A. 1986; 83(2):261-4. PMC: 322837. DOI: 10.1073/pnas.83.2.261. View

Reinemann C, Strehlitz B . Aptamer-modified nanoparticles and their use in cancer diagnostics and treatment. Swiss Med Wkly. 2014; 144:w13908. DOI: 10.4414/smw.2014.13908. View

Sahin S, Caglayan M, Ustundag Z . Recent advances in aptamer-based sensors for breast cancer diagnosis: special cases for nanomaterial-based VEGF, HER2, and MUC1 aptasensors. Mikrochim Acta. 2020; 187(10):549. DOI: 10.1007/s00604-020-04526-x. View

Hermann T, Patel D . Adaptive recognition by nucleic acid aptamers. Science. 2000; 287(5454):820-5. DOI: 10.1126/science.287.5454.820. View

10.

Kong H, Byun J . Screening and characterization of a novel RNA aptamer that specifically binds to human prostatic acid phosphatase and human prostate cancer cells. Mol Cells. 2015; 38(2):171-9. PMC: 4332034. DOI: 10.14348/molcells.2015.2272. View

11.

Wang J, Guo X, Liu R, Guo J, Zhang Y, Zhang W . Detection of carcinoembryonic antigen using a magnetoelastic nano-biosensor amplified with DNA-templated silver nanoclusters. Nanotechnology. 2019; 31(1):015501. DOI: 10.1088/1361-6528/ab4506. View

12.

Liang J, Luo G, Ning X, Shi Y, Zhai H, Sun S . Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein. Biochem Cell Biol. 2007; 85(3):375-83. DOI: 10.1139/o07-052. View

13.

Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W . Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987; 235(4785):177-82. DOI: 10.1126/science.3798106. View

14.

Gu Z, Biswas A, Zhao M, Tang Y . Tailoring nanocarriers for intracellular protein delivery. Chem Soc Rev. 2011; 40(7):3638-55. DOI: 10.1039/c0cs00227e. View

15.

Sharifi M, Attar F, Saboury A, Akhtari K, Hooshmand N, Hasan A . Plasmonic gold nanoparticles: Optical manipulation, imaging, drug delivery and therapy. J Control Release. 2019; 311-312:170-189. DOI: 10.1016/j.jconrel.2019.08.032. View

16.

Cheng N, Song Y, Fu Q, Du D, Luo Y, Wang Y . Aptasensor based on fluorophore-quencher nano-pair and smartphone spectrum reader for on-site quantification of multi-pesticides. Biosens Bioelectron. 2018; 117:75-83. PMC: 8672368. DOI: 10.1016/j.bios.2018.06.002. View

17.

Shiao Y, Chiu H, Wu P, Huang Y . Aptamer-functionalized gold nanoparticles as photoresponsive nanoplatform for co-drug delivery. ACS Appl Mater Interfaces. 2014; 6(24):21832-41. DOI: 10.1021/am5026243. View

18.

Xu Y, Jiang X, Zhou Y, Ma M, Wang M, Ying B . Systematic Evolution of Ligands by Exponential Enrichment Technologies and Aptamer-Based Applications: Recent Progress and Challenges in Precision Medicine of Infectious Diseases. Front Bioeng Biotechnol. 2021; 9:704077. PMC: 8383106. DOI: 10.3389/fbioe.2021.704077. View

19.

Wu Y, Feng Y, Li X . Classification of breast cancer by a gold nanoparticle based multicolor fluorescent aptasensor. J Colloid Interface Sci. 2021; 611:287-293. DOI: 10.1016/j.jcis.2021.12.039. View

20.

Aryal S, Nguyen T, Pitchaimani A, Shrestha T, Biller D, Troyer D . Membrane Fusion-Mediated Gold Nanoplating of Red Blood Cell: A Bioengineered CT-Contrast Agent. ACS Biomater Sci Eng. 2021; 3(1):36-41. DOI: 10.1021/acsbiomaterials.6b00573. View